The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
De novo molecular design and generative models
Open accessAbstract
Molecular design strategies are integral to therapeutic progress in drug discovery. Computational approaches for de novo molecular design have been developed over the past three decades and, recently, thanks in part to advances in machine learning (ML) and artificial intelligence (AI), the drug discovery field has gained practical experience. Here, we review these learnings and present de novo approaches according to the coarseness of their molecular representation: that is, whether molecular design is modeled on an atom-based, fragment-based, or reaction-based paradigm. Furthermore, we emphasize the value of strong benchmarks, describe the main challenges to using these methods in practice, and provide a viewpoint on further opportunities for exploration and challenges to be tackled in the upcoming years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Planning chemical syntheses with deep neural networks and symbolic AI
Segler, M. H. S., Preuss, M., & Waller, M. P. (2018) · Nature · doi:10.1038/nature25978 · Cited by 1,847
Deep learning enables rapid identification of potent DDR1 kinase inhibitors
Zhavoronkov, A., Ivanenkov, Y. A., Aliper, A., Veselov, M. S., Aladinskiy, V. A., Aladinskaya, A. V., Terentiev, V. A., Polykovskiy, D. A., Kuznetsov, M. D., Asadulaev, A., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0224-x · Cited by 1,573
GuacaMol: Benchmarking Models for de Novo Molecular Design
Brown, N., Fiscato, M., Segler, M. H. S., & Vaucher, A. C. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00839 · Cited by 895
Self-citationDeep learning for molecular design—a review of the state of the art
Elton, D. C., Boukouvalas, Z., Fuge, M. D., & Chung, P. W. (2019) · Molecular Systems Design & Engineering · doi:10.1039/c9me00039a · Cited by 683
REINVENT 2.0: An AI Tool for De Novo Drug Design
Blaschke, T., Arús-Pous, J., Chen, H., Margreitter, C., Tyrchan, C., Engkvist, O., Papadopoulos, K., & Patronov, A. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00915 · Cited by 496
The unreasonable effectiveness of deep learning in artificial intelligence
Sejnowski, T. J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1907373117 · Cited by 352
When Quality Beats Quantity: Decision Theory, Drug Discovery, and the Reproducibility Crisis
Scannell, J. W., & Bosley, J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0147215 · Cited by 279
Assessing the impact of generative AI on medicinal chemistry
Walters, W. P., & Murcko, M. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0418-2 · Cited by 262
Research works printed but not linked: 83
- Emmert-Streib F, Yang Z, Feng H, Tripathi S, Dehmer M. An introductory review of deep learning for prediction models with big data. Front Artif Intell Published online February 28, 2020. https://doi.org/10.3389/frai.2020.00004. · DOI · Paper page
- Bickerton, 2012, Quantifying the chemical beauty of drugs, Nat Chem, 4, 90, 10.1038/nchem.1243 · DOI · Paper page
- Kusner MJ, Paige B, Hernández-Lobato JM. Grammar variational autoencoder. arXiv [statML]. Published online March 6, 2017. http://arxiv.org/abs/1703.01925. · arXiv
- Firth, 2015, MOARF, an integrated workflow for multiobjective optimization: implementation, synthesis, and biological evaluation, J Chem Inf Model, 55, 1169, 10.1021/acs.jcim.5b00073 · DOI
- Polykovskiy D, Zhebrak A, Sanchez-Lengeling B, Golovanov S, Tatanov O, Belyaev S, et al. Molecular Sets (MOSES): a benchmarking platform for molecular generation models. arXiv [csLG]. Published online November 29, 2018. http://arxiv.org/abs/1811.12823. · arXiv
- Sanchez-Lengeling, 2018, Inverse molecular design using machine learning: Generative models for matter engineering, Science, 361, 360, 10.1126/science.aat2663 · DOI · Paper page
- Xu, 2019, Deep learning for molecular generation, Future Med Chem, 11, 567, 10.4155/fmc-2018-0358 · DOI
- Fabian B, Edlich T, Gaspar H, Segler M, Meyers J, Fiscato M, et al. Molecular representation learning with language models and domain-relevant auxiliary tasks. arXiv [csLG]. Published online November 26, 2020. http://arxiv.org/abs/2011.13230. · arXiv
- Schneider, 2015, Get your atoms in order–an open-source implementation of a novel and robust molecular canonicalization algorithm, J Chem Inf Model, 55, 2111, 10.1021/acs.jcim.5b00543 · DOI
- Bjerrum, 2018, Improving chemical autoencoder latent space and molecular de novo generation diversity with heteroencoders, Biomolecules, 8, 131, 10.3390/biom8040131 · DOI
- Prykhodko, 2019, A de novo molecular generation method using latent vector based generative adversarial network, J Cheminform, 11, 74, 10.1186/s13321-019-0397-9 · DOI · Paper page
- Arús-Pous, 2019, Randomized SMILES strings improve the quality of molecular generative models, J Cheminform, 11, 71, 10.1186/s13321-019-0393-0 · DOI · Paper page
- O’Boyle N, Dalke A. DeepSMILES: an adaptation of SMILES for use in machine-learning of chemical structures. ChemRxiv, Published online September 18, 2018. https://doi.org/10.26434/chemrxiv.7097960.v1. · DOI
- Krenn, 2020, SELFIES: a robust representation of semantically constrained graphs with an example application in chemistry, Mach Learn Sci Technol, 1
- Brown, 2004, A graph-based genetic algorithm and its application to the multiobjective evolution of median molecules, J Chem Inf Comput Sci, 44, 1079, 10.1021/ci034290p · DOI
- Reutlinger, 2014, Multi-objective molecular de novo design by adaptive fragment prioritization, Angew Chem Int Ed Engl, 53, 4244, 10.1002/anie.201310864 · DOI
- Jensen, 2019, A graph-based genetic algorithm and generative model/Monte Carlo tree search for the exploration of chemical space, Chem Sci, 10, 3567, 10.1039/C8SC05372C · DOI · Paper page
- Yoshikawa, 2018, Population-based de novo molecule generation, using grammatical evolution, Chem Lett, 47, 1431, 10.1246/cl.180665 · DOI
- Winter, 2019, Efficient multi-objective molecular optimization in a continuous latent space, Chem Sci, 10, 8016, 10.1039/C9SC01928F · DOI · Paper page
- Kwon, 2021, MolFinder: an evolutionary algorithm for the global optimization of molecular properties and the extensive exploration of chemical space using SMILES, J Cheminform, 13, 24, 10.1186/s13321-021-00501-7 · DOI
- Verhellen, 2020, Illuminating elite patches of chemical space, Chem Sci, 11, 11485, 10.1039/D0SC03544K · DOI
- Lewell, 1998, RECAP–retrosynthetic combinatorial analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry, J Chem Inf Comput Sci, 38, 511, 10.1021/ci970429i · DOI · Paper page
- Polishchuk, 2020, CReM: chemically reasonable mutations framework for structure generation, J Cheminform, 12, 28, 10.1186/s13321-020-00431-w · DOI
- Vinkers, 2003, SYNOPSIS: SYNthesize and OPtimize system in silico, J Med Chem, 46, 2765, 10.1021/jm030809x · DOI
- Spiegel, 2020, AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization, J Cheminform, 12, 25, 10.1186/s13321-020-00429-4 · DOI
- Hartenfeller, 2011, A collection of robust organic synthesis reactions for in silico molecule design, J Chem Inf Model, 51, 3093, 10.1021/ci200379p · DOI
- Ghiandoni, 2020, Enhancing reaction-based de novo design using a multi-label reaction class recommender, J Comput Aided Mol Des, 34, 783, 10.1007/s10822-020-00300-6 · DOI
- Segler, 2018, Generating focused molecule libraries for drug discovery with recurrent neural networks, ACS Cent Sci, 4, 120, 10.1021/acscentsci.7b00512 · DOI · Paper page
- Simonovsky M, Komodakis N. GraphVAE: towards generation of small graphs using variational autoencoders. In: Artificial Neural Networks and Machine Learning – ICANN 2018. London: Springer International Publishing; 2018: 412–422. · DOI · Paper page
- De Cao N, Kipf T. MolGAN: An implicit generative model for small molecular graphs. arXiv [statML]. Published online May 30, 2018. http://arxiv.org/abs/1805.11973. · arXiv
- Liu, 2018, Constrained graph variational autoencoders for molecule design, Adv Neural Inf Process Syst, 31, 7795
- Li Y, Vinyals O, Dyer C, Pascanu R, Battaglia P. Learning deep generative models of graphs. arXiv [csLG]. Published online March 8, 2018. http://arxiv.org/abs/1803.03324. · arXiv
- Zhou, 2019, Optimization of molecules via deep reinforcement learning, Sci Rep, 9, 10752, 10.1038/s41598-019-47148-x · DOI · Paper page
- Mercado, 2020, Graph networks for molecular design, Mach Learn Sci Technol, 2
- Lynch, 1996, The Sheffield generic structures project: a retrospective review, J Chem Inf Comput Sci, 36, 930, 10.1021/ci950173l · doi:10.1021/ci950173l
- Pogány, 2019, De novo molecule design by translating from reduced graphs to SMILES, J Chem Inf Model, 59, 1136, 10.1021/acs.jcim.8b00626 · DOI
- Jin W, Barzilay R, Jaakkola T. Junction tree variational autoencoder for molecular graph generation. arXiv [csLG]. Published online February 12, 2018. http://arxiv.org/abs/1802.04364. · arXiv
- Ståhl, 2019, Deep reinforcement learning for multiparameter optimization in de novo drug design, J Chem Inf Model, 59, 3166, 10.1021/acs.jcim.9b00325 · DOI
- Button, 2019, Automated de novo molecular design by hybrid machine intelligence and rule-driven chemical synthesis, Nat Mach Intell, 1, 307, 10.1038/s42256-019-0067-7 · DOI
- Bradshaw, 2019, A model to search for synthesizable molecules, Adv Neural Inf Process Syst, 32, 7937
- Korovina, 2020, ChemBO: Bayesian optimization of small organic molecules with synthesizable recommendations, Proc Machine Learn Res, 108, 3393
- Horwood J, Noutahi E. Molecular design in synthetically accessible chemical space via deep reinforcement learning. arXiv [physics.chem–ph]. Published online April 29, 2020. http://arxiv.org/abs/2004.14308. · arXiv
- Gottipati SK, Sattarov B, Niu S, Pathak Y, Wei H, Liu S, et al. Learning to navigate the synthetically accessible chemical space using reinforcement learning. arXiv [csLG]. Published online April 26, 2020. http://arxiv.org/abs/2004.12485. · arXiv
- Bradshaw J, Paige B, Kusner MJ, Segler MHS, Hernández-Lobato JM. Barking up the right tree: an approach to search over molecule synthesis DAGs. arXiv [csLG]. Published online December 21, 2020. http://arxiv.org/abs/2012.11522. · arXiv
- Boitreaud, 2020, OptiMol: Optimization of binding affinities in chemical space for drug discovery, J Chem Inf Model, 60, 5658, 10.1021/acs.jcim.0c00833 · DOI
- von Lilienfeld, 2020, Exploring chemical compound space with quantum-based machine learning, Nat Rev Chem, 4, 347, 10.1038/s41570-020-0189-9 · DOI · Paper page
- Ghanakota, 2020, Combining cloud-based free-energy calculations, synthetically aware enumerations, and goal-directed generative machine learning for rapid large-scale chemical exploration and optimization, J Chem Inf Model, 60, 4311, 10.1021/acs.jcim.0c00120 · DOI
- Gillet, 1994, SPROUT: recent developments in the de novo design of molecules, J Chem Inf Comput Sci, 34, 207, 10.1021/ci00017a027 · DOI
- Imrie, 2020, Deep generative models for 3D linker design, J Chem Inf Model, 60, 1983, 10.1021/acs.jcim.9b01120 · DOI · Paper page
- Skalic, 2019, Shape-based generative modeling for de novo drug design, J Chem Inf Model, 59, 1205, 10.1021/acs.jcim.8b00706 · DOI · Paper page
- Simm GNC, Pinsler R, Hernández-Lobato JM. Reinforcement learning for molecular design guided by quantum mechanics. arXiv [statML]. Published online February 18, 2020. http://arxiv.org/abs/2002.07717. · arXiv
- Schneider, 2019, Automated de novo drug design: are we nearly there yet?, Angew Chem Int Ed Engl, 58, 10792, 10.1002/anie.201814681 · DOI · Paper page
- Assmann M, Bal M, Craig M, D’Oyley J, Phillips L, Triendl H, et al. A novel machine learning approach uncovers new and distinctive inhibitors for cyclin-dependent kinase 9. bioRxiv. Published online March 19, 2020. http://dx.doi/org/10.1101/2020.03.18.996538. · DOI
- Perron Q, Mirguet O, Tajmouati H, Skiredj A, Rojas A, Gohier A, et al. Deep generative models for ligand-based de Novo design applied to multi–parametric optimization. ChemRxiv. Published online January 25, 2021. http://dx.doi/org/10.26434/chemrxiv.13622417.v2. · doi:10.26434/chemrxiv.13622417.v1
- Li, 2020, Chemical space exploration based on recurrent neural networks: applications in discovering kinase inhibitors, J Cheminform, 12, 42, 10.1186/s13321-020-00446-3 · DOI
- Grisoni F, Huisman B, Button A, Moret M, Atz K, Merk D, et al. Combining generative artificial intelligence and on-chip synthesis for de novo drug design. ChemRxiv. Published online December 30, 2020. http://dx.doi/org/10.26434/chemrxiv.13498587.v1. · doi:10.26434/chemrxiv.13498587.v1
- Kaushik, 2020, AI-driven drug discovery: a boon against COVID-19?, AI Open, 1, 1, 10.1016/j.aiopen.2020.07.001 · DOI
- Arús-Pous, 2020, SMILES-based deep generative scaffold decorator for de-novo drug design, J Cheminform, 12, 38, 10.1186/s13321-020-00441-8 · DOI
- Jin, 2020, Multi-objective molecule generation using interpretable substructures, Proc Mach Learn Res, 119, 4849
- Lim, 2020, Scaffold-based molecular design with a graph generative model, Chem Sci, 11, 1153, 10.1039/C9SC04503A · DOI
- Gao, 2020, The synthesizability of molecules proposed by generative models, J Chem Inf Model, 60, 5714, 10.1021/acs.jcim.0c00174 · DOI · Paper page
- Makara, 2021, Derivatization design of synthetically accessible space for optimization: in silico synthesis vs deep generative design, ACS Med Chem Lett, 12, 185, 10.1021/acsmedchemlett.0c00540 · DOI
- Vaucher, 2020, Automated extraction of chemical synthesis actions from experimental procedures, Nat Commun, 11, 3601, 10.1038/s41467-020-17266-6 · DOI
- Nicolaou, 2013, Multi-objective optimization methods in drug design, Drug Discov Today Technol, 10, e427, 10.1016/j.ddtec.2013.02.001 · DOI
- Grebner, 2020, Automated de novo design in medicinal chemistry: which types of chemistry does a generative neural network learn?, J Med Chem, 63, 8809, 10.1021/acs.jmedchem.9b02044 · DOI
- Ecemis, 2008, A drug candidate design environment using evolutionary computation, IEEE Trans Evol Comput, 12, 591, 10.1109/TEVC.2007.913131 · doi:10.1109/tevc.2007.913131
- Lameijer, 2006, The molecule evoluator. an interactive evolutionary algorithm for the design of drug-like molecules, J Chem Inf Model, 46, 545, 10.1021/ci050369d · DOI
- Renz, 2019, On failure modes in molecule generation and optimization, Drug Discov Today Technol, 32–33, 55, 10.1016/j.ddtec.2020.09.003 · DOI
- Brown, 2006, A novel workflow for the inverse QSPR problem using multiobjective optimization, J Comput Aided Mol Des, 20, 333, 10.1007/s10822-006-9063-1 · DOI
- Bush, 2020, A Turing test for molecular generators, J Med Chem, 63, 11964, 10.1021/acs.jmedchem.0c01148 · DOI
- Zhang J, Mercado R, Engkvist O, Chen H. Comparative study of deep generative models on chemical space coverage. ChemRxiv. Published online November 16, 2020. https://doi.org/10.26434/chemrxiv.13234289.v3. · doi:10.26434/chemrxiv.13234289.v1
- Coley, 2020, Autonomous discovery in the chemical sciences part II: outlook, Angew Chem Int Ed Engl, 59, 23414, 10.1002/anie.201909989 · DOI
- Cieplinski T, Danel T, Podlewska S, Jastrzebski S. We should at least be able to design molecules that dock well. arXiv [q-bioBM]. Published online June 20, 2020. http://arxiv.org/abs/2006.16955. · arXiv
- Nigam A, Friederich P, Krenn M, Aspuru-Guzik A. Augmenting genetic algorithms with deep neural networks for exploring the chemical space. arXiv [csNE]. Published online September 25, 2019. http://arxiv.org/abs/1909.11655. · arXiv
- Shi C, Xu M, Zhu Z, Zhang W, Zhang M, Tang J. GraphAF: a flow-based autoregressive model for molecular graph generation. arXiv [csLG]. Published online January 26, 2020. http://arxiv.org/abs/2001.09382. · arXiv
- Madhawa K, Ishiguro K, Nakago K, Abe M. GraphNVP: an invertible flow model for generating molecular graphs. arXiv [statML]. Published online May 28, 2019. http://arxiv.org/abs/1905.11600. · arXiv
- Xu M, Ran T, Chen H. De Novo molecule design through molecular generative model conditioned by 3D information of protein binding sites. ChemRxiv. Published online December 30, 2020. https://doi.org/10.26434/chemrxiv.13498332.v1. · doi:10.26434/chemrxiv.13498332.v1
- Simonovsky, 2020, DeeplyTough: learning structural comparison of protein binding sites, J Chem Inf Model, 60, 2356, 10.1021/acs.jcim.9b00554 · DOI
- Méndez-Lucio, 2020, De novo generation of hit-like molecules from gene expression signatures using artificial intelligence, Nat Commun, 11, 10, 10.1038/s41467-019-13807-w · DOI · Paper page
- Born, 2021, PaccMannRL: de novo generation of hit-like anticancer molecules from transcriptomic data via reinforcement learning, iScience, 24, 10.1016/j.isci.2021.102269 · DOI
- Zhavoronkov, 2020, Reply to “Assessing the impact of generative AI on medicinal chemistry”, Nat Biotechnol, 38, 10.1038/s41587-020-0417-3 · DOI
- Bajorath J. Faculty Opinions Recommendation of “Assessing the impact of generative AI on medicinal chemistry”. Faculty Opinions. Published online February 11, 2020; https://doi.org/10.3410/f.737286584.793570630. · doi:10.3410/f.737286584.793570630
- Chen, 2019, Has drug design augmented by artificial intelligence become a reality?, Trends Pharmacol Sci, 40, 806, 10.1016/j.tips.2019.09.004 · DOI
Cited by
Generative machine learning for de novo drug discovery: A systematic review
Martinelli, D. D. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105403 · Cited by 177
Artificial Intelligence Technologies for COVID-19 De Novo Drug Design
Floresta, G., Zagni, C., Gentile, D., Patamia, V., & Rescifina, A. (2022) · doi:10.20944/preprints202203.0032.v1 · Cited by 67
Kochman, U., Sitka, H., Kuźniar, J., Czaja, M., Kozubek, P., Beszłej, J. A., & Leszek, J. (2026) · Molecular Neurobiology · doi:10.1007/s12035-025-05417-z · Cited by 60
Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence
Duran-Frigola, M., Cigler, M., & Winter, G. E. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c11098 · Cited by 50
Can We Quickly Learn to “Translate” Bioactive Molecules with Transformer Models?
Tysinger, E. P., Rai, B. K., & Sinitskiy, A. V. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c01618 · Cited by 23
Enhancing high-fidelity neural network potentials through low-fidelity sampling
Jung, G. S. (2024) · APL Machine Learning · doi:10.1063/5.0222779 · Cited by 2
Metadata
- Authors
- Meyers, J., Fabian, B., & Brown, N.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2021-11
- Volume
- 26
- Issue
- 11
- Pages
- 2707-2715
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W3165171933
- Cited by
- 292
- References
- 8
- FWCI
- 23.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.